ARS Pharmaceuticals, Inc. · NASDAQ:SPRY

ARS Pharmaceuticals, Inc. financial statements

ARS Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue84.3M89.1M30.0K1.32M5.51M17.8M
Cost of revenue20.4M20.6M017.1M213.0K14.1M1.55M1.42M
Gross profit63.9M68.6M30.0K-15.8M5.29M3.77M-1.55M-1.42M
Research and development13.2M19.6M20.3M18.4M20.3M24.6M21.5M14.8M
Selling, general and administrative230.1M71.7M47.3M603.0K4.69M4.23M
Operating income-179.4M-3.08M-67.5M-35.5M-19.5M-32.9M-24.1M-18.3M
Depreciation and amortization1.37M79.0K100.0K100.0K213.0K637.0K1.55M1.42M
EBITDA-178.1M-3.00M-67.4M-35.4M-19.2M-32.3M-22.5M-16.9M
Interest expense2.60M0834.0K106.0K29.0K
Income before tax-171.4M8.29M-54.4M-34.7M-20.2M-1.06M-24.0M-17.6M
Income tax-80.0K288.0K0000
Net income-171.3M8.00M-54.4M-34.7M-20.2M-32.9M-24.0M-17.6M
Earnings per share, basic-1.740.08-0.57-0.87-0.70-11.33-0.72-0.53
Earnings per share, diluted-1.740.08-0.57-0.87-0.70-11.33

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents41.3M50.8M71.0M210.5M60.1M386.6M9.98M20.2M
Short-term investments203.7M263.2M157.4M63.9M0
Receivables25.3M8.18M01.01M1.00K384.0K
Inventory31.4M10.5M0-1.01M-6.78M-2.61M
Current assets284.9M334.3M231.7M277.7M60.7M390.7M10.5M20.8M
Property, plant and equipment2.46M1.07M574.0K329.0K72.0K1.62M
Total assets327.7M351.2M233.2M281.4M61.4M394.8M15.6M27.5M
Accounts payable5.72M9.87M759.0K1.66M1.79M2.58M3.52M775.0K
Current liabilities39.1M23.4M2.39M5.44M8.19M9.60M17.9M5.14M
Long-term debt96.4M4.93M7.46M
Total debt96.4M0274.0K481.0K9.03M10.0M15.6M7.73M
Total liabilities213.4M94.4M2.43M8.55M16.7M11.9M21.3M9.35M
Shareholders' equity114.3M256.8M230.8M272.9M-31.3M-14.1M-5.60M18.2M
Shares outstanding99.3M98.0M96.4M93.9M30.4M34.7M33.1M33.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-170.9M13.5M-59.3M-40.1M-17.6M-31.2M-18.9M-16.9M
Capital spending-339.0K-563.0K-175.0K-199.0K-55.0K-917.0K-96.0K-449.0K
Free cash flow-171.2M13.0M-59.4M-40.3M-17.6M-32.1M-19.0M-17.3M
Cash from investing56.8M-106.1M-87.2M-199.0K-55.0K-917.0K-96.0K-449.0K
Cash from financing104.6M72.4M6.90M190.7M53.2M408.5M8.61M19.4M
Share buybacks570.0K
Change in cash-9.50M-20.2M-139.5M150.5M35.5M14.2M-10.2M2.08M